Taking Zentel Medicine during pregnancy is generally not recommended due to potential risks to the developing fetus. Albendazole can cause harm, especially during the first trimester when the baby’s organs are forming. It is classified as a Category C drug by the FDA, meaning animal studies have shown adverse effects, but there are no adequate human studies.
If treatment is essential, it should be under strict medical supervision, weighing the benefits and risks. Women of childbearing age are advised to take effective contraceptive measures during treatment and for one month after completing the medication. Always consult your healthcare provider for personalized advice.
